Publications<< Back
de la Torre Hernández JM, Masotti Centol M, Lerena Saenz P, Sánchez Recalde Á, Gimeno de Carlos F, Piñón Esteban P, Fernandez Rodriguez D, Sitges Carreño M, Sabate Tenas M, Zueco Gil J
Effectiveness and safety beyond 10 years of percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
Rev Esp Cardiol (Engl Ed). 2014 May;67(5):353-8, PMID: 24774727
Percutaneous transluminal septal ablation is an alternative treatment in patients with hypertrophic obstructive cardiomyopathy. However, due to the relatively new introduction of this technique, there is no information on its very long term results (>10 years).
CARDIAC & CARDIOVASCULAR SYSTEMS
An initiative of
